Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SENS-111 in Acute Unilateral Vestibulopathy
NCT03110458Phase 2Completed
- Sponsor
- Sensorion
- Start
- Aug 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of seliforant in acute unilateral vestibulopathy (AUVP), sponsored by Sensorion. Started Aug 2017; status: completed.
02
Drugs
seliforant
03
Conditions
acute unilateral vestibulopathy (AUVP)
Beyond the preview
Go deeper on NCT03110458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110458.